TLS 
Triyambak Life Sciences

Nurturing Life Sciences

TLS Online

Nurturing Life Sciences

Store
Login

Practice Questions

  1. Home
  2. Free Resources
  3. Practice Questions
  4. 11734
TLS Online TPP Program

#Question id: 1904


What is the target of the monoclonal antibody basiliximab used to help suppress allograft rejection?

#Section 2: General Biology
  1. CD3

  2. CD40L

  3. LFA-1

  4. CD25


Answer:- Option(s): 4


To access the video solutions, Please subscribe TPP program.

Subscribe Now 
More Questions
TLS Online TPP Program

#Question id: 18764

#Section 7: Recombinant DNA technology and Other Tools in Biotechnology

which of the following statement is incorrect about loop modelling?

TLS Online TPP Program

#Question id: 1590

#Section 2: General Biology

An epitope associates with which part of an antibody?

TLS Online TPP Program

#Question id: 4344

#Section 3: Genetics, Cellular and Molecular Biology

How does the transcription of structural genes in an inducible operon occur?

TLS Online TPP Program

#Question id: 4812

#Section 3: Genetics, Cellular and Molecular Biology

Two character X and Y ,both follow law of dominance due to 3:1 F2 phenotypic ratio monohybrid cross separately If carry out dihybrid selfing cross for heterozygous genotype for both character does not follow law of independence assortment in normal environmental condition due to?

TLS Online TPP Program

#Question id: 1424

#Section 3: Genetics, Cellular and Molecular Biology

Gain-of-function mutations in which of the following genes typify colorectal carcinomas?

TLS Triyambak Life Sciences Nurturing Life Sciences
TLS Android APP TLS IOS APP

Company

  • About us
  • Careers
  • Terms of service
  • Privacy policy

Help & Support

  • User Guidelines
  • Refund Policy

Products

  • TLS APP
  • TPP APP

Contact Us

117/429-4 Q Block, behind Hotel DNG Grand, Sharda Nagar, Kanpur,
Uttar Pradesh 208025
India
Phone: +91 9919149001, +917007912133
Email: info@triyambak.org

© 2025 Copyright Triyambak Life Sciences Pvt Ltd. All Rights Reserved